Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Rahul G Argula, Celine Ward & Carol Feghali-Bostwick. (2019) Therapeutic Challenges And Advances In The Management Of Systemic Sclerosis-Related Pulmonary Arterial Hypertension (SSc-PAH). Therapeutics and Clinical Risk Management 15, pages 1427-1442.
Read now
Read now
R Hesselstrand, M Wildt, B Ekmehag, DM Wuttge & A Scheja. (2011) Survival in patients with pulmonary arterial hypertension associated with systemic sclerosis from a Swedish single centre: prognosis still poor and prediction difficult. Scandinavian Journal of Rheumatology 40:2, pages 127-132.
Read now
Read now
N Tsifetaki, AN Georgiadis, Y Alamanos, S Fanis, MI Argyropoulou & AA Drosos. (2010) Subclinical atherosclerosis in scleroderma patients. Scandinavian Journal of Rheumatology 39:4, pages 326-329.
Read now
Read now
G Cuomo, C Santoriello, F Polverino, L Ruocco, G Valentini & M Polverino. (2010) Impaired exercise performance in systemic sclerosis and its clinical correlations. Scandinavian Journal of Rheumatology 39:4, pages 330-335.
Read now
Read now
H Harðardóttir, HAC van Helvoort, MC Vonk, FHJ van den Hoogen, PNR Dekhuijzen & YF Heijdra. (2010) Exercise in systemic sclerosis intensifies systemic inflammation and oxidative stress. Scandinavian Journal of Rheumatology 39:1, pages 63-70.
Read now
Read now
P Szodoray, L Varoczy, G Szegedi & M Zeher. (2010) Autologous stem cell transplantation in autoimmune and rheumatic diseases: from the molecular background to clinical applications. Scandinavian Journal of Rheumatology 39:1, pages 1-11.
Read now
Read now
Articles from other publishers (21)
Isabella M. Atzeni, Yehya Al-Adwi, Berber Doornbos-van der Meer, Caroline Roozendaal, Alja Stel, Harry van Goor, C. Tji Gan, Michael Dickinson, Wim Timens, Andries J. Smit, Johanna Westra & Douwe J. Mulder. (2023) The soluble receptor for advanced glycation end products is potentially predictive of pulmonary arterial hypertension in systemic sclerosis. Frontiers in Immunology 14.
Crossref
Crossref
Takashi Kida, Keiichi Matsuzaki, Isao Yokota, Nozomu Kawase, Masatoshi Kadoya, Hironori Inoue, Yuji Kukida, Shunya Kaneshita, Takuya Inoue, Makoto Wada, Masataka Kohno, Wataru Fukuda, Yutaka Kawahito & Taku Iwami. (2022) Latent trajectory modelling of pulmonary artery pressure in systemic sclerosis: a retrospective cohort study. RMD Open 8:2, pages e002673.
Crossref
Crossref
Mor Zaaroor Levy, Noa Rabinowicz, Maia Yamila Kohon, Avshalom Shalom, Ariel Berl, Tzipi Hornik-Lurie, Liat Drucker, Shelly Tartakover Matalon & Yair Levy. (2022) MiRNAs in Systemic Sclerosis Patients with Pulmonary Arterial Hypertension: Markers and Effectors. Biomedicines 10:3, pages 629.
Crossref
Crossref
Djúlio César Zanin-Silva, Maynara Santana-Gonçalves, Marianna Yumi Kawashima-Vasconcelos & Maria Carolina Oliveira. (2021) Management of Endothelial Dysfunction in Systemic Sclerosis: Current and Developing Strategies. Frontiers in Medicine 8.
Crossref
Crossref
Kaitlin A. Quinn, Stephanie R. Wappel, Tunay Kuru & Virginia D. Steen. (2020) Exercise Echocardiography Predicts Future Development of Pulmonary Hypertension in a High-risk Cohort of Patients with Systemic Sclerosis. The Journal of Rheumatology 47:5, pages 708-713.
Crossref
Crossref
John W. Swisher & Shashank Kailash. 2019. New Insights into Systemic Sclerosis [Working Title]. New Insights into Systemic Sclerosis [Working Title].
José Pedro L. Nunes, André C. Cunha, Tiago Meirinhos, Alzira Nunes, Paulo M. Araújo, Ana R. Godinho, Eduardo M. Vilela & Carlos Vaz. (2018) Prevalence of auto-antibodies associated to pulmonary arterial hypertension in scleroderma – A review. Autoimmunity Reviews 17:12, pages 1186-1201.
Crossref
Crossref
Chieh-Yu Shen, Ko-Jen Li, Pei-Hsuan Lai, Chia-Li Yu & Song-Chou Hsieh. (2017) Anti-CENP-B and anti-TOPO-1-containing sera from systemic sclerosis-related diseases with Raynaud’s phenomenon induce vascular endothelial cell senescence not via classical p53-p21 pathway. Clinical Rheumatology 37:3, pages 749-756.
Crossref
Crossref
Sneha M. Sundaram & Lorinda Chung. (2018) An Update on Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: a Review of the Current Literature. Current Rheumatology Reports 20:2.
Crossref
Crossref
Wen-Tao Ma, Christopher Chang, M. Eric Gershwin & Zhe-Xiong Lian. (2017) Development of autoantibodies precedes clinical manifestations of autoimmune diseases: A comprehensive review. Journal of Autoimmunity 83, pages 95-112.
Crossref
Crossref
Zsuzsanna H. McMahan, Frederick M. Wigley & Livia Casciola‐Rosen. (2017) Risk of Digital Vascular Events in Scleroderma Patients Who Have Both Anticentromere and Anti–Interferon‐Inducible Protein 16 Antibodies. Arthritis Care & Research 69:6, pages 922-926.
Crossref
Crossref
Kathleen Morrisroe, Molla Huq, Wendy Stevens, Candice Rabusa, Susanna M. Proudman & Mandana Nikpour. (2016) Risk factors for development of pulmonary arterial hypertension in Australian systemic sclerosis patients: results from a large multicenter cohort study. BMC Pulmonary Medicine 16:1.
Crossref
Crossref
Antonia Valenzuela, Saranya Nandagopal, Virginia D. Steen & Lorinda Chung. (2015) Monitoring and Diagnostic Approaches for Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis. Rheumatic Disease Clinics of North America 41:3, pages 489-506.
Crossref
Crossref
Gloria A. Salazar, Shervin Assassi, Fredrick Wigley, Laura Hummers, John Varga, Monique Hinchcliff, Dinesh Khanna, Elena Schiopu, Kristine Phillips, Daniel E. Furst, Virginia Steen, Murray Baron, Marie Hudson, Suzanne S. Taillefer, Janet Pope, Niall Jones, Peter Docherty, Nader A. Khalidi, David Robinson, Robert W. Simms, Richard M. Silver, Tracy M. Frech, Barri J. Fessler, Jerry A. Molitor, Marvin J. Fritzler, Barbara M. Segal, Firas Al-Kassab, Marilyn Perry, Jeremy Yang, Sara Zamanian, John D. Reveille, Frank C. Arnett, Claudia Pedroza & Maureen D. Mayes. (2015) Antinuclear antibody-negative systemic sclerosis. Seminars in Arthritis and Rheumatism 44:6, pages 680-686.
Crossref
Crossref
Yanjie Hao, Vivek Thakkar, Wendy Stevens, Kathleen Morrisroe, David Prior, Candice Rabusa, Peter Youssef, Eli Gabbay, Janet Roddy, Jennifer Walker, Jane Zochling, Joanne Sahhar, Peter Nash, Susan Lester, Maureen Rischmueller, Susanna M Proudman & Mandana Nikpour. (2015) A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis. Arthritis Research & Therapy 17:1, pages 7.
Crossref
Crossref
Guang Song, Chaojun Hu, Heng Zhu, Li Wang, Fengchun Zhang, Yongzhe Li & Lin Wu. (2013) New Centromere Autoantigens Identified in Systemic Sclerosis Using Centromere Protein Microarrays. The Journal of Rheumatology 40:4, pages 461-468.
Crossref
Crossref
Aaliya Yaqub & Lorinda Chung. (2012) Epidemiology and Risk Factors for Pulmonary Hypertension in Systemic Sclerosis. Current Rheumatology Reports 15:1.
Crossref
Crossref
Sita Naik. (2012) Laboratory tests and the paediatric rheumatologist: What does he need to know?. Indian Journal of Rheumatology 7:1, pages 106-111.
Crossref
Crossref
Lorinda Chung, Juliana Liu, Lori Parsons, Paul M. Hassoun, Michael McGoon, David B. Badesch, Dave P. Miller, Mark R. Nicolls & Roham T. Zamanian. (2010) Characterization of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension From REVEAL. Chest 138:6, pages 1383-1394.
Crossref
Crossref
Luciana Breda, Manuela Nozzi, Sara De Sanctis & Francesco Chiarelli. (2010) Laboratory Tests in the Diagnosis and Follow-Up of Pediatric Rheumatic Diseases: An Update. Seminars in Arthritis and Rheumatism 40:1, pages 53-72.
Crossref
Crossref
M. Ali Raza. (2009) The presence of anti-centromere antibodies may predict progression of estimated pulmonary arterial systolic pressure in systemic sclerosis. Yearbook of Pulmonary Disease 2009, pages 200-201.
Crossref
Crossref